BIG1 Stock Overview
Provides technologies and customized solutions for health and hygiene in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Bio-Gate AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.98 |
| 52 Week High | €1.80 |
| 52 Week Low | €0.53 |
| Beta | 0.18 |
| 11 Month Change | -7.94% |
| 3 Month Change | 12.57% |
| 1 Year Change | -7.94% |
| 33 Year Change | -74.74% |
| 5 Year Change | n/a |
| Change since IPO | -99.35% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BIG1 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -2.5% | 2.8% | 2.8% |
| 1Y | -7.9% | -0.5% | 4.1% |
Return vs Industry: BIG1 underperformed the German Chemicals industry which returned -0.5% over the past year.
Return vs Market: BIG1 underperformed the German Market which returned 4.1% over the past year.
Price Volatility
| BIG1 volatility | |
|---|---|
| BIG1 Average Weekly Movement | 8.0% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: BIG1 has not had significant price volatility in the past 3 months.
Volatility Over Time: BIG1's weekly volatility has decreased from 14% to 8% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 42 | Marc Lloret-Grau | www.bio-gate.de |
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives.
Bio-Gate AG Fundamentals Summary
| BIG1 fundamental statistics | |
|---|---|
| Market cap | €8.41m |
| Earnings (TTM) | -€1.62m |
| Revenue (TTM) | €7.31m |
1.2x
P/S Ratio-5.2x
P/E RatioIs BIG1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIG1 income statement (TTM) | |
|---|---|
| Revenue | €7.31m |
| Cost of Revenue | €3.43m |
| Gross Profit | €3.88m |
| Other Expenses | €5.50m |
| Earnings | -€1.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 53.07% |
| Net Profit Margin | -22.20% |
| Debt/Equity Ratio | 12.1% |
How did BIG1 perform over the long term?
See historical performance and comparison